Antithymocyte immunoglobulin (rabbit)

含有 Antithymocyte immunoglobulin (rabbit) 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

GRAFALON 20 MG/ML I.V. INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTRE (1 FLAKON)条形码：8699684980047
GRAFALON 5 ML IV INFUZYONLUK COZELTI KONSANTRESI ICEREN 1 FLAKON条形码：8699684980023

食物注意事项

该活性成分暂无已收录的食物注意事项。

最重要的相互作用

前 10 项，共 50 项

Abciximab中等
当 Abciximab 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abciximab is combined with Antithymocyte immunoglobulin (rabbit).
Adalimumab中等
当 Adalimumab 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adalimumab is combined with Antithymocyte immunoglobulin (rabbit).
Aldesleukin中等
当 Aldesleukin 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antithymocyte immunoglobulin (rabbit).
Alefacept中等
当 Alefacept 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alefacept is combined with Antithymocyte immunoglobulin (rabbit).
Alemtuzumab中等
当 Alemtuzumab 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Antithymocyte immunoglobulin (rabbit).
Anakinra中等
当 Anakinra 与 Antithymocyte immunoglobulin (rabbit) 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Anakinra is combined with Antithymocyte immunoglobulin (rabbit).
2-Methoxyethanol中等
当 Antithymocyte immunoglobulin (rabbit) 与 2-Methoxyethanol 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A中等
当 Antithymocyte immunoglobulin (rabbit) 与 9-(N-methyl-L-isoleucine)-cyclosporin A 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abagovomab中等
当 Antithymocyte immunoglobulin (rabbit) 与 Abagovomab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Abagovomab.
Abatacept中等
当 Antithymocyte immunoglobulin (rabbit) 与 Abatacept 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Abatacept.